Tech Company Financing Transactions
SAVA Funding Round
SAVA, based in London, secured $8 million from Balderton Capital, EXOR and private investors.
Transaction Overview
Company Name
Announced On
6/21/2024
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
Balderton Capital (Lead Investor)
EXOR (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its team, design its product line with manufacturing capability, and demonstrate the platform's clinical performance.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
117 Charterhouse Street
London, EC1M 6AA
UK
London, EC1M 6AA
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.
Management Team
Browse more venture capital transactions:
Prev: 6/21/2024: Elixir Games venture capital transaction
Next: 6/21/2024: Char.gy venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs